Synthesis and in Vitro Anticancer Activity of Certain Novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas As Apoptosis-inducing Agents

Overview

Journal J Enzyme Inhib Med Chem

Specialty Biochemistry

Date 2019 Feb 7

PMID 30722708

Citations 32

Authors

Wagdy M Eldehna

Ghada S Hassan

Sara T Al-Rashood

Tarfah Al-Warhi

Ahmed E Altyar

Hamad M Alkahtani

Abdulrahman A Almehizia

Hatem A Abdel-Aziz

Affiliations

Soon will be listed here.

Abstract

In connection with our research program on the development of novel anticancer candidates, herein we report the design and synthesis of novel series of 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas 5a-l. The target pyridins were evaluated for their in vitro anticancer activity against two cancer cell lines: non-small cell lung cancer A549 cell line and colon cancer HCT-116 cell line. Compound 5l emerged as the most active congener towards both A549 and HCT-116 cell lines with IC values equal to 3.22 ± 0.2 and 2.71 ± 0.16 µM, respectively, which are comparable to those of Doxorubicin; 2.93 ± 0.28 and 3.10 ± 0.22, respectively. Furthermore, compound 5l stood out as the most potent pyridine derivative (mean % GI = 40), at US-NCI Developmental Therapeutic Program anticancer assay, with broad-spectrum antitumor activity against the most tested cancer cell lines from all subpanels. Compound 5l was able to provoke apoptosis in HCT-116 cells as evidenced by the decreased expression of the anti-apoptotic Bcl-2 protein, and the enhanced expression of the pro-apoptotic proteins levels; Bax, cytochrome C, p53, caspase-3 and caspase-9. Moreover, 5l disrupted the HCT-116 cell cycle via alteration of the Sub-G phase and arresting the G-M stage. Also, 5l showed a significant increase in the percent of annexinV-FITC positive apoptotic cells from 1.99 to 15.76%.

Citing Articles

Discovery of 1-benzo[]imidazole-(halogenated) Benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors.

Mirgany T, Asiri H, Rahman A, Alanazi M Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065690 PMC: 11279404. DOI: 10.3390/ph17070839.

Inhibitory Effect of Two Carbonic Anhydrases Inhibitors on the Activity of Major Cytochrome P450 Enzymes.

Elbarbry F, Ibrahim T, Abdelrahman M, Supuran C, Eldehna W Eur J Drug Metab Pharmacokinet. 2024; 49(5):583-594.

PMID: 38914798 DOI: 10.1007/s13318-024-00903-6.

Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents-In Vitro Evaluation against Breast Cancer Cells.

Guillen-Mancina E, Garcia-Lozano M, Burgos-Moron E, Mazzotta S, Martinez-Aguado P, Calderon-Montano J Int J Mol Sci. 2023; 24(23).

PMID: 38069364 PMC: 10706865. DOI: 10.3390/ijms242317041.

Discovery of New Pyrrolo[2,3-]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers.

AlOtaibi A, Alanazi M, Rahman A Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765132 PMC: 10536928. DOI: 10.3390/ph16091324.

Novel 7-Deazapurine Incorporating Isatin Hybrid Compounds as Protein Kinase Inhibitors: Design, Synthesis, In Silico Studies, and Antiproliferative Evaluation.

Alanazi M, Alanazi A Molecules. 2023; 28(15).

PMID: 37570839 PMC: 10420662. DOI: 10.3390/molecules28155869.

References

Eldehna W, Abo-Ashour M, Nocentini A, Gratteri P, Eissa I, Fares M . Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies. Eur J Med Chem. 2017; 139:250-262. DOI: 10.1016/j.ejmech.2017.07.073. View

Roed Skarderud M, Polk A, Vistisen K, Larsen F, Nielsen D . Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review. Cancer Treat Rev. 2017; 62:61-73. DOI: 10.1016/j.ctrv.2017.10.011. View

Ismail R, Abou-Seri S, Eldehna W, Ismail N, Elgazwi S, Ghabbour H . Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells. Eur J Med Chem. 2018; 155:782-796. DOI: 10.1016/j.ejmech.2018.06.024. View

El-Naggar M, Eldehna W, Almahli H, Elgez A, Fares M, Elaasser M . Novel Thiazolidinone/Thiazolo[3,2-]Benzimidazolone-Isatin Conjugates as Apoptotic Anti-proliferative Agents Towards Breast Cancer: One-Pot Synthesis and In Vitro Biological Evaluation. Molecules. 2018; 23(6). PMC: 6099623. DOI: 10.3390/molecules23061420. View

Abdel-Aziz H, Eldehna W, Keeton A, Piazza G, Kadi A, Attwa M . Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling. Drug Des Devel Ther. 2017; 11:2333-2346. PMC: 5557401. DOI: 10.2147/DDDT.S140164. View

Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D . Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst. 1991; 83(11):757-66. DOI: 10.1093/jnci/83.11.757. View

Abdel-Aziz H, Eldehna W, Ghabbour H, Al-Ansary G, Assaf A, Al-Dhfyan A . Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents. Int J Mol Sci. 2016; 17(8). PMC: 5000619. DOI: 10.3390/ijms17081221. View

Eldehna W, Ibrahim H, Abdel-Aziz H, Farrag N, Youssef M . Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones. Eur J Med Chem. 2014; 89:549-60. DOI: 10.1016/j.ejmech.2014.10.064. View

Zhang L, Yu J . Role of apoptosis in colon cancer biology, therapy, and prevention. Curr Colorectal Cancer Rep. 2013; 9(4). PMC: 3836193. DOI: 10.1007/s11888-013-0188-z. View

10.

Almahli H, Hadchity E, Jaballah M, Daher R, Ghabbour H, Kabil M . Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer. Bioorg Chem. 2018; 77:443-456. DOI: 10.1016/j.bioorg.2018.01.034. View

11.

Jiang H, Zhao P, Su D, Feng J, Ma S . Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo. Mol Med Rep. 2014; 9(6):2265-72. DOI: 10.3892/mmr.2014.2108. View

12.

Eldehna W, Altoukhy A, Mahrous H, Abdel-Aziz H . Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents. Eur J Med Chem. 2014; 90:684-94. DOI: 10.1016/j.ejmech.2014.12.010. View

13.

Abdel-Aziz H, Ghabbour H, Eldehna W, Al-Rashood S, Al-Rashood K, Fun H . 2-((Benzimidazol-2-yl)thio)-1-arylethan-1-ones: Synthesis, crystal study and cancer stem cells CD133 targeting potential. Eur J Med Chem. 2015; 104:1-10. DOI: 10.1016/j.ejmech.2015.09.023. View

14.

Soliman D, Eldehna W, Ghabbour H, Kabil M, Abdel-Aziz M, Abdel-Aziz H . Novel 6-Phenylnicotinohydrazide Derivatives: Design, Synthesis and Biological Evaluation as a Novel Class of Antitubercular and Antimicrobial Agents. Biol Pharm Bull. 2017; 40(11):1883-1893. DOI: 10.1248/bpb.b17-00361. View

15.

Eldehna W, Abou-Seri S, El Kerdawy A, Ayyad R, Hamdy A, Ghabbour H . Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives. Eur J Med Chem. 2016; 113:50-62. DOI: 10.1016/j.ejmech.2016.02.029. View

16.

Sabt A, Abdelhafez O, El-Haggar R, Madkour H, Eldehna W, El-Din A M El-Khrisy E . Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies. J Enzyme Inhib Med Chem. 2018; 33(1):1095-1107. PMC: 6022226. DOI: 10.1080/14756366.2018.1477137. View

17.

Delbridge A, Grabow S, Strasser A, Vaux D . Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer. 2016; 16(2):99-109. DOI: 10.1038/nrc.2015.17. View

18.

Cohen G . Caspases: the executioners of apoptosis. Biochem J. 1997; 326 ( Pt 1):1-16. PMC: 1218630. DOI: 10.1042/bj3260001. View

19.

McIlwain D, Berger T, Mak T . Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 2013; 5(4):a008656. PMC: 3683896. DOI: 10.1101/cshperspect.a008656. View

20.

Shimizu S, Narita M, Tsujimoto Y . Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 1999; 399(6735):483-7. DOI: 10.1038/20959. View